Human clinical trials magnify the ballooning of clinical research

Research Article
*Raghavendra Rao M. V., N. Uday Goutham. M. M. Karindas., G. Pavani., SumanaSen. A. Neeraja and D. Srinivasa Rao
DOI: 
DOI: http://dx.doi.org/10.24327/ijrsr.20231412.0824
Subject: 
Medical
KeyWords: 
Clinical trials, Public health, Drug Standard Control Organization (CDSCO), “vaccine efficacy”, Therapeutic Efficacy
Abstract: 

Clinical research has undergone a lengthy and fascinating history. Humans are used as test subjects in human clinical trials research, which is a form of scientific investigation. Human clinical trials are used to test new procedures and medications and determine how they affect patient outcomes. Clinical research informs clinical practice and evidence-based medicine. When novel drugs are tested on humans, there are various potential ethical problems. In highly developed countries like the USA and UK, clinical trials are subject to strict regulations, extensive safety measures, and compensation responsibilities. Finding volunteers is a time-consuming and expensive process in western countries. Clinical investigations are currently expanding, particularly in China, India, and other nations. Due to its strong regulatory environment, illiteracy, poverty, lack of awareness about clinical trials, and broken healthcare system, India was a suitable destination to outsource human clinical studies. India has been deemed one of the most promising centers of activity for clinical trials due to the large number of available patients who are treatment-naive, the low cost, and the large number of qualified professionals. Clinical trials are reliable, practical, and available in India